Emerald Advisers’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Emerald Advisers’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-304,330	Closed	-$11.4M	–	282
2018 Q1	$11.4M	Buy	+304,330	New	+$12.8M	0.46%	96

Emerald Advisers's ARMO Position: Q2 2018 in Review

Emerald Advisers sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 304,330 shares — an estimated $11.4M sold.

Emerald Advisers first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $11.4M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Emerald Advisers reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Emerald Advisers sold 304,330 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $11.4M.
Emerald Advisers first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Emerald Advisers's ARMO BioSciences, Inc. Common Stock position peaked at $11.4M in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Emerald Advisers's 13F filing for Q2 2018, filed 31 Jul 2018.